Neurovascular and inflammatory effects of biperiden in the acute phase of moderate traumatic brain injury: evidence from a non-human primate model

Viviam Sanabria, Christiane Gimenes, Simone Romariz, Amarildo Souza Gois, Matheus B Braga, Michele Longoni Calió, Juliana Lima Willers, Maira L Foresti, Luiz Eugênio Mello, Beatriz M Longo · 2026

Read Neurovascular and inflammatory effects of biperiden in the acute phase of moderate traumatic brain injury: evidence from a non-human primate model by Viviam Sanabria, Christiane Gimenes, Simone Romariz, Amarildo Souza Gois, Matheus B Braga, Michele Longoni Calió, Juliana Lima Willers, Maira L Foresti, Luiz Eugênio Mello, Beatriz M Longo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13547420.txt.

Description

Viviam Sanabria and a Brazilian team tested in 2026 whether biperiden, a drug that blocks one acetylcholine receptor family, can protect the brain in the first day after a moderate head injury. Traumatic injury triggers a surge of that chemical messenger, which can overexcite cells. Thirty-nine marmosets received a controlled lateral fluid percussion injury, then repeated drug doses starting six hours later or a salt solution.

A day after injury, treated animals showed less dying tissue in the hippocampus, lower levels of a neuronal damage marker in blood and tissue, and calmer astrocyte activation than controls. The drug's exact receptor target inside the brain was not directly checked. The authors present biperiden as an early intervention candidate worth further primate work.

Catalog record

CREATORViviam Sanabria, Christiane Gimenes, Simone Romariz, Amarildo Souza Gois, Matheus B Braga, Michele Longoni Calió, Juliana Lima Willers, Maira L Foresti, Luiz Eugênio Mello, Beatriz M Longo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60868
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13547420

Browse the full library · About the Tower of Babel